Literature DB >> 21554875

Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al.

Barry J Hoffer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21554875     DOI： 10.1016/j.expneurol.2011.04.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  3 in total

Review 1.  Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.

Authors:  Tingting Tang; Yong Li; Qian Jiao; Xixun Du; Hong Jiang
Journal:  Neurosci Bull       Date:  2017-03-23       Impact factor: 5.203

2.  Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity.

Authors:  Lizheng Wang; Zixuan Wang; Xiaoyu Xu; Rui Zhu; Jinpeng Bi; Wenmo Liu; Xinyao Feng; Hui Wu; Haihong Zhang; Jiaxin Wu; Wei Kong; Bin Yu; Xianghui Yu
Journal:  Int J Med Sci       Date:  2017-03-17       Impact factor: 3.738

3.  Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.

Authors:  Lizheng Wang; Zixuan Wang; Rui Zhu; Jinpeng Bi; Xinyao Feng; Wenmo Liu; Jiaxin Wu; Haihong Zhang; Hui Wu; Wei Kong; Bin Yu; Xianghui Yu
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.